Literature DB >> 18024267

Pathologic alterations of the heart and the kidney in patients with ankylosing spondylitis.

U Lange1, G Stapfer, T Ditting, H Geiger, J Teichmann, U Müller-Ladner, O Jung.   

Abstract

BACKGROUND: The occurrence of a variety of pathological lesions of the heart and kidneys have been described in patients with ankylosing spondylitis (AS). The frequency of these alterations and whether they are specific for AS has been discussed controversially. -
METHODS: Outpatients with AS were studied to determine the frequency of cardiac and renal alterations and to assess the associated clinical and demographic factors. -
RESULTS: A total of 77 patients with AS participated in the study (male 84.4%, mean age 48.3 +/- 1.5 years, mean duration of disease 15.4 +/- 1.2 years). Hypertension was present in 36.4% and diabetes mellitus in 13.0%. Impaired renal function (defined by a decrease in GFR) combined with markers of kidney damage suspective for chronic kidney disease were present in 3 patients (3.9%). Pathologic alterations of the heart were found in 25 patients (37.3%). Echocardiographic abnormalities were present in 20 patients (e.g. aortic and mitral insufficiency). Electrocardiographic abnormalities were present in 12 patients (e.g. atrioventricular, left and right branch block). Patients with cardiac abnormalities were older (54.2 +/- 2.9 vs. 44.9 +/- 1.7 years) and had a longer duration of disease (20.6 +/- 2.1 vs. 13.9 +/- 1.6 years) as compared to non-affected patients. -
CONCLUSION: In our study, cardiac abnormalities were frequently seen in patients with AS, while renal disease was more rare and might be due to diseases not related to AS in most of patients. In contrast to cardiac involvement, it therefore appears questionable, that chronic kidney disease is part of the extraskeletal manifestations, or at least that AS has a high impact on renal integrity.

Entities:  

Mesh:

Year:  2007        PMID: 18024267

Source DB:  PubMed          Journal:  Eur J Med Res        ISSN: 0949-2321            Impact factor:   2.175


  5 in total

Review 1.  Cardiovascular and cerebrovascular diseases in ankylosing spondylitis: current insights.

Authors:  Michael T Nurmohamed; Irene van der Horst-Bruinsma; Walter P Maksymowych
Journal:  Curr Rheumatol Rep       Date:  2012-10       Impact factor: 4.592

2.  The effects of golimumab treatment on systolic and diastolic left ventricular function in ankylosing spondylitis.

Authors:  S C Heslinga; T C Konings; I E van der Horst-Bruinsma; O Kamp; V P van Halm; Hacm de Bruin-Bon; M J Peters; M T Nurmohamed
Journal:  Biologics       Date:  2018-11-08

3.  Membranous nephropathy and thymoma in a patient with ankylosing spondylitis: A case report.

Authors:  Lirong Lin; Lei Zhao; Bengang Huo; Luquan Zheng; Rongjie Yu; Weibing Li; Jurong Yang
Journal:  Medicine (Baltimore)       Date:  2020-05       Impact factor: 1.817

4.  Gender Is a Risk Factor for Annual Decline in Estimated Glomerular Filtration Rate in Patients Treated with Biological DMARDs in Rheumatoid Arthritis and Ankylosing Spondylitis: a Retrospective Observational Study.

Authors:  Seong-Kyu Kim; Jung-Yoon Choe
Journal:  J Korean Med Sci       Date:  2018-05-28       Impact factor: 2.153

5.  Cardiac conduction disturbances in patients with ankylosing spondylitis: results from a 5-year follow-up cohort study.

Authors:  Karin Bengtsson; Eva Klingberg; Anna Deminger; Hanna Wallberg; Lennart T H Jacobsson; Lennart Bergfeldt; Helena Forsblad-d'Elia
Journal:  RMD Open       Date:  2019-11-13
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.